NanoViricides Inc. (NNVC)

[NNVClover]

Supply constraints for vaccines are caused by cumbersome manufacturing. We still make these things in chicken cells. Increasingly cell-based manufacturing has sped the process up. These products weren't nearly as profitable as their pharmaceutical counterparts... new targets and diseases were in endless supply until the 90s/00s. Increasingly, the impact of generic drugs and fewer medical problems to solve pharmacologically helped the pharmaceutical world realize vaccines are a valuable, high-margin asset. I don't think the legal environment means much. Companies love making flu vaccines--SNY has been doing it for 100 years. MRK NVS GSK Solvay Crucell BAX and many others find it very profitable.

I am a pharmaceutical investor for a living. Ask me anything!